Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Assessment of Bruxism and Treatment Response Using Digital Occlusal Analysis: A Clinical Study of Botulinum Toxin-A

NCT07640035 is registered in ClinicalTrials.gov with Bilecik Seyh Edebali Universitesi as lead sponsor.

NCT NCT07640035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07640035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Assessment of Bruxism and Treatment Response Using Digital Occlusal Analysis: A Clinical Study of Botulinum Toxin-A
Lead sponsor
Bilecik Seyh Edebali Universitesi
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
July 20, 2027
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bruxism